首页> 外文期刊>RSC Advances >Synthesis and biological evaluation of novel analogues of batracylin with synthetic amino acids and adenosine: an unexpected effect on centromere segregation in tumor cells through a dual inhibition of topoisomerase IIα and Aurora B
【24h】

Synthesis and biological evaluation of novel analogues of batracylin with synthetic amino acids and adenosine: an unexpected effect on centromere segregation in tumor cells through a dual inhibition of topoisomerase IIα and Aurora B

机译:用合成氨基酸和腺苷的新乳蛋白新型类似物的合成与生物学评价:通过拓扑异构酶IIα和极光B的双重抑制对肿瘤细胞Centromere偏析的意外效果

获取原文
           

摘要

In the search for new anticancer agents we designed and synthesized batracylin derivatives with linking synthetic amino acid side chains of different lengths and adenosine. Unexpectedly, we have found that in water and the culture media adenosine–amino acid–BAT conjugates form supramolecular structures and this prevents these compounds from entering cells. Consequently, these compounds exerted no biological activity when tested towards two human cell lines, lung adenocarcinoma (A549) and human leukemia (HL-60). In contrast, several amino acid–BAT precursors showed up to 25-fold enhanced cytotoxic activity compared to BAT and these compounds strongly interfered with DNA topoisomerase II activity and its cellular functions. In particular, these conjugates inhibited centromere segregation during mitosis in drug-treated tumor cells by preventing topoisomerase II-dependent Aurora B activation.
机译:在寻找新的抗癌剂,我们设计和合成的肉肉蛋白衍生物,其具有连接的不同长度和腺苷的合成氨基酸侧链。出乎意料的是,我们发现在水和培养介质腺苷 - 氨基酸 - 蝙蝠缀合物形成超分子结构,这可以防止这些化合物进入细胞。因此,当朝向两种人细胞系,肺腺癌(A549)和人白血病(HL-60)测试时,这些化合物没有生物活性。相比之下,与蝙蝠相比,几种氨基酸-BAT前体显示出高达25倍的细胞毒性活性,并且这些化合物强烈干扰DNA拓扑异构酶II活性及其细胞功能。特别地,这些缀合物通过预防拓扑异构酶II依赖性极光B活化来抑制药物处理的肿瘤细胞中的细胞分子中的焦粒子偏析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号